(Q51024780)
Statements
A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Apraclonidine Primary Therapy Study Group. (English)
1 reference
W C Stewart
1 reference
R Laibovitz
1 reference
B Horwitz
1 reference
R H Stewart
1 reference
R Ritch
1 reference
M Kottler
1 reference
1 August 1996
1 reference
114
1 reference
8
1 reference
938-942
1 reference